Nitisinone and Meropenem: Interaction Details

Brand names
Nitisinone
OrfadinNityrHarliku
Same medicines, other forms
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Nitisinone

Brand names
  • Orfadin
  • Nityr
  • Harliku

What Happens When You Take Nitisinone With Meropenem

What can happen when they are taken together (rated Major)

Increased OAT1 or OAT3 exposure and an increased risk of OAT1 or OAT3 substrate-related adverse effects

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Nitisinone inhibits OAT1 and OAT3, so giving it together with substrates of either can raise substrate exposure and may heighten the risk of adverse effects. Patients should be watched for adverse reactions linked to the substrate drug when it is used alongside nitisinone. In a study where nitisinone 80 mg once daily was given with a 20 mg IV dose of furosemide (a substrate of OAT1 and OAT3), furosemide rose by 72% and rose by 12%.21

The Nitisinone and Meropenem Interaction, Explained

Nitisinone can make meropenem stay in your body longer. Meropenem is an antibiotic that your kidneys clear using helper proteins called OAT1 and OAT3. Nitisinone can slow those proteins down. In a study with a different drug cleared this way (furosemide), exposure rose by about 72%. So you could have more meropenem in your system than expected, which may raise the chance of side effects such as stomach upset, diarrhea, headache, or rash, and less commonly seizures.

Keep taking both exactly as prescribed. Let your pharmacist or doctor know you use both. Your care team can watch you more closely and adjust your treatment if needed.

Mechanism: Nitisinone inhibits OAT1 and OAT3 ( organic anion ). Meropenem is renally eliminated and is an OAT , so reduced tubular secretion is expected to increase meropenem exposure. Neither drug's activity depends on activation.

  • Direction: increased substrate exposure and risk of dose-related adverse effects (e.g., effects, rash, and effects including seizure risk, especially with renal impairment).
  • Magnitude: not studied with meropenem. With furosemide (OAT1/OAT3 substrate), rose 72% and 12%.
  • Evidence: probable. Onset unspecified. Severity on file: major.
  • Management: monitor for substrate-related adverse reactions. Consider renal function and individualize meropenem dosing as needed.

See the 2 references behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Nitisinone and Meropenem Interact

The likely mechanism

of OAT1-mediated by nitisinone; inhibition of OAT3-mediated metabolism by nitisinone

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Nitisinone and Meropenem Interaction

Your care team can usually manage this by watching for side effects rather than avoiding the combination.

  • Keep taking both medicines as prescribed. Do not stop or change either one on your own.
  • Your team may monitor you more closely while you use both, and the meropenem dose may need to be adjusted and individualized.
  • Tell your pharmacist or prescriber right away about new or worsening diarrhea, nausea, rash, headache, or any unusual symptoms.
  • Make sure everyone treating you knows you take nitisinone.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Nitisinone or Meropenem need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: NITYR oral tablets, nitisinone oral tablets

    of nitisinone 80 mg once daily with a single 20 mg IV dose of furosemide (an OAT1/OAT3 ) raised the of furosemide by 72% and its by 12%.21

Nitisinone and Meropenem: Common Questions

How serious is the Nitisinone and Meropenem interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Nitisinone and Meropenem interaction managed?

Your care team can usually manage this by watching for side effects rather than avoiding the combination. Keep taking both medicines as prescribed. Do not stop or change either one on your own. Your team may monitor you more closely while you use both, and the meropenem dose may need to be adjusted and individualized. Tell your pharmacist or prescriber right away about new or worsening diarrhea, n… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Nitisinone and Meropenem Interaction

Ask in your own words about taking Nitisinone and Meropenem together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (2)

  1. Product Information: HARLIKU(TM) oral tablets, nitisinone oral tablets. Cycle Pharmaceuticals Ltd (per FDA), Boston, MA, 2025. DailyMed
  2. Product Information: NITYR(R) oral tablets, nitisinone oral tablets. Cycle Pharmaceuticals Ltd (per FDA), Lexington, KY, 2020. DailyMed
Was this write-up helpful?

Other Serious Interactions of Nitisinone and Meropenem

Also serious with Meropenem

Also serious with Nitisinone

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Meropenem

With Nitisinone

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, as soon as they can.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.